[(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone

C22H26F2N4O — CID 165421011

IUPAC[(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone
SMILESCn1nccc1C(=O)N1C[C@@H]2C[C@H](C1)[C@@H]1CCC[C@H](c3cc(F)cc(F)c3)N1C2
InChIInChI=1S/C22H26F2N4O/c1-26-21(5-6-25-26)22(29)27-11-14-7-16(13-27)20-4-2-3-19(28(20)12-14)15-8-17(23)10-18(24)9-15/h5-6,8-10,14,16,19-20H,2-4,7,11-13H2,1H3/t14-,16+,19+,20-/m0/s1
InChIKeyFBNMDGBPLFJRLK-NBPAUJCUSA-N
MW400.47 g/mol
LogP3.39
Rot. Bonds2

About [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone

[(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone (PubChem CID 165421011) has the molecular formula C22H26F2N4O and a molecular weight of 400.47 g/mol. Its IUPAC name is [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone.

Molecular Properties

Compound Name[(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone
PubChem CID165421011
Molecular FormulaC22H26F2N4O
Molecular Weight400.47 g/mol
Exact Mass400.21
IUPAC Name[(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone
SMILESCn1nccc1C(=O)N1C[C@@H]2C[C@H](C1)[C@@H]1CCC[C@H](c3cc(F)cc(F)c3)N1C2
InChIInChI=1S/C22H26F2N4O/c1-26-21(5-6-25-26)22(29)27-11-14-7-16(13-27)20-4-2-3-19(28(20)12-14)15-8-17(23)10-18(24)9-15/h5-6,8-10,14,16,19-20H,2-4,7,11-13H2,1H3/t14-,16+,19+,20-/m0/s1
InChIKeyFBNMDGBPLFJRLK-NBPAUJCUSA-N
XLogP3.39
TPSA41.37 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds2
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500400.47
LogP ≤ 53.39
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Analyze [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone?
The IUPAC name of [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone (CID 165421011) is [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone.
What is the SMILES notation for [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone?
The canonical SMILES for [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone is Cn1nccc1C(=O)N1C[C@@H]2C[C@H](C1)[C@@H]1CCC[C@H](c3cc(F)cc(F)c3)N1C2.
What is the InChIKey of [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone?
The InChIKey is FBNMDGBPLFJRLK-NBPAUJCUSA-N. The full InChI is InChI=1S/C22H26F2N4O/c1-26-21(5-6-25-26)22(29)27-11-14-7-16(13-27)20-4-2-3-19(28(20)12-14)15-8-17(23)10-18(24)9-15/h5-6,8-10,14,16,19-20H,2-4,7,11-13H2,1H3/t14-,16+,19+,20-/m0/s1.
What are the key properties of [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone?
[(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone has a molecular weight of 400.47 g/mol, XLogP of 3.39, 2 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(1R,2S,6R,9R)-6-(3,5-difluorophenyl)-7,11-diazatricyclo[7.3.1.02,7]tridecan-11-yl]-(2-methylpyrazol-3-yl)methanone is sourced from PubChem (CID 165421011), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).